Table 5. Univariate and multivariate analysis of prognostic factors.
| Variable | Disease-free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
| Univariate | Multivariate | p-value | Univariate | Multivariate | p-value | |
| Age >65 yr | 3.45 (2.04-5.85) | 3.45 (2.04-5.85) | <0.001 | 2.97 (1.74-5.05) | 2.61 (1.50-4.53) | <0.001 |
| Adjuvant therapy | 0.70 (0.54-0.90) | 0.70 (0.54-0.90) | 0.011 | 0.68 (0.52-0.89) | 0.67 (0.49-0.93) | 0.016 |
| MMI >50% | 1.81 (1.02-3.19) | 1.81 (1.02-3.19) | 0.112 | 1.71 (0.94-3.10) | 1.58 (0.81-3.07) | 0.178 |
| Stage III | 0.85 (0.52-1.40) | 1.70 (0.90-3.24) | 0.105 | 0.76 (0.45-1.27) | 1.55 (0.81-2.98) | 0.190 |
| LVSI (+) | 0.79 (0.47-1.35) | 0.83 (0.47-1.48) | 0.531 | 0.73 (0.42-1.27) | 0.77 (0.43-1.40) | 0.395 |
| Grade 3 | 1.39 (0.84-2.29) | 1.09 (0.61-1.93) | 0.770 | 1.48 (0.88-2.48) | 1.19 (0.66-2.14) | 0.562 |
| PLND+PALND | 0.79 (0.53-1.17) | 0.78 (0.50-1.20) | 0.258 | 0.67 (0.44-1.02) | 0.67 (0.42-1.05) | 0.082 |
Values are presented as odds ratio (95% confidence interval).
LVSI, lymphovascular space involvement; MMI, myometrial invasion; PALND, paraaortic lymph node dissection; PLND, pelvic lymph node dissection.